Circulating Methylated-HOXA9 Tumor DNA as a Biomarker in Recurrent Breast Cancer

In this MEDtalk, MD Stine Bakkesen Bruun presents interesting findings on a potential new biomarker for prognosis and mortality in recurrent breast cancer. The biomarker is circulating methylated-HOXA9 tumor DNA, as this gene may act as a tumor suppressor in carcinomas and induce breast cancer progression.